XML 31 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Note 2 - Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Exercise price per warrant

 $33.00 

Conversion rate - common shares per warrant

  1.50 

Closing price of common stock

 $23.72 

Volatility

  75%

Risk-free interest rate

  5.40%

Expected life of option (in years)

  0.3 

Dividend yield

 

zero

 
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2025

  

2024

  

2025

  

2024

 

Operating expenses

                

Research and development

 $(3,955) $(17,676) $(22,737) $(49,107)

General and administrative

  (7,905)  (12,947)  (59,101)  (62,852)

Other segment items(a)

  1,053   2,680   3,404   115,214 

Net income (loss)

 $(10,807) $(27,943) $(78,434) $3,255 
    
  

September 30, 2025

  

December 31, 2024

 

Cash and cash equivalents

 $106,080  $128,574 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2025

  

2024

  

2025

  

2024

 

Numerator, basic:

                

Net income (loss)

 $(10,807) $(27,943) $(78,434) $3,255 

Denominator, basic:

                

Weighted average common shares outstanding

  48,308   47,976   48,293   45,734 

Net income (loss) per share, basic

 $(0.22) $(0.58) $(1.62) $0.07 
                 

Numerator, diluted:

                

Net income (loss)

 $(10,807) $(27,943) $(78,434) $3,255 

Adjustment for change in fair value of warrant liabilities

           (43,793)

Adjusted numerator, diluted

 $(10,807) $(27,943) $(78,434) $(40,538)

Denominator, diluted:

                

Weighted average common shares outstanding

  48,308   47,976   48,293   45,734 

Dilutive effect of common stock warrants

           367 

Weighted average dilutive common shares

  48,308   47,976   48,293   46,101 

Net loss per share, diluted

 $(0.22) $(0.58) $(1.62) $(0.88)
                 

Dilutive common stock options excluded from net income (loss) per share, diluted

  4,101   2,949   3,975   2,772 

Dilutive Performance Awards excluded from net income (loss) per share, diluted

  7   7   7   7